A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC). [electronic resource]
Producer: 20000612Description: 145-57 p. digitalISSN:- 0169-5002
- Adult
- Aged
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Area Under Curve
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Combined Modality Therapy
- Docetaxel
- Europe
- Female
- Humans
- Infusions, Intravenous
- Lung Neoplasms -- drug therapy
- Male
- Mexico
- Middle Aged
- Paclitaxel -- administration & dosage
- Palliative Care
- Quality of Life
- Survival Analysis
- Taxoids
- United States
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.